初次就诊后延迟至多180天开始IVF治疗不影响卵巢储备功能减退女性的妊娠结局
该回顾性队列研究纳入1790例卵巢储备功能减退(AMH<1.1 ng/ml)不孕患者,比较初次就诊后1-90天(即早组1115例)与91-180天(延迟组675例)启动IVF周期的活产率,发现两组活产率相似(早组23.9% vs 延迟组25.6%,OR 1.08,95%CI 0.85-1.38),在AMH<0.5 ng/ml及>40岁且AMH<1.1 ng/ml亚组中亦无显著差异。
要点
- 延迟至多180天启动IVF不影响卵巢储备功能减退患者的活产率。
- AMH<0.5 ng/ml亚组活产率早组18.8% vs 延迟组19.1%(OR 0.99,95%CI 0.65-1.51)。
- >40岁且AMH<1.1 ng/ml亚组活产率早组12.3% vs 延迟组14.7%(OR 1.21,95%CI 0.77-1.91)。
核心结论
- 初次就诊后延迟至多180天启动IVF治疗不影响卵巢储备功能减退患者的活产率。
- 该观察结果在高危应答不良患者中同样成立。
- 作者认为当因医疗、后勤或经济原因需要短期延迟治疗时,提供者和患者应放心治疗结局不会受影响。
研究设计与样本
- 回顾性队列研究,在学术医院环境中纳入卵巢储备功能减退(AMH<1.1 ng/ml)不孕患者。
- 共1790例符合纳入标准(早组1115例,延迟组675例),每例仅纳入一个周期,仅分析新鲜胚胎移植周期,未纳入基因检测胚胎。
- 患者按周期启动时间分组:初次就诊后1-90天(早组)或91-180天(延迟组)。
- 主要结局为活产(≥24周妊娠)。
- 对更严重的卵巢储备功能减退进行亚组分析:AMH<0.5 ng/ml及>40岁且AMH<1.1 ng/ml(博洛尼亚标准)。
主要发现
- 从就诊到IVF启动的平均±标准差天数:早组50.5±21.9天,延迟组128.8±25.9天。
- 胚胎移植后活产率两组相似:早组23.9% vs 延迟组25.6%(OR 1.08,95%CI 0.85-1.38)。
- AMH<0.5 ng/ml亚组活产率相似:早组18.8% vs 延迟组19.1%(OR 0.99,95%CI 0.65-1.51)。
- >40岁且AMH<1.1 ng/ml亚组活产率相似:早组12.3% vs 延迟组14.7%(OR 1.21,95%CI 0.77-1.91)。
关键数值与推荐
- 卵巢储备功能减退定义为AMH<1.1 ng/ml。
- 早组为周期在就诊后1-90天启动,延迟组为91-180天启动。
- 主要结局活产定义为≥24周妊娠。
- 亚组分析采用AMH<0.5 ng/ml及>40岁且AMH<1.1 ng/ml(博洛尼亚标准)。
临床怎么用
- 作者认为当因医疗、后勤或经济原因需要短期延迟治疗时,提供者和患者应放心治疗结局不会受影响。
- 研究结果仅适用于完成IVF周期(取卵)的卵巢储备功能减退患者。
局限性
- 存在选择偏倚的可能,涉及初次就诊后90天内与91-180天启动IVF周期的患者比较。
- 未纳入初次评估后未进行取卵IVF治疗的患者,因此结果仅适用于完成IVF周期的卵巢储备功能减退患者。
- 排除了初次就诊后超过180天启动IVF周期的患者,因此未知此类延迟对IVF周期妊娠结局的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Will a delay in initiating IVF treatment affect pregnancy outcomes in infertile women with diminished ovarian reserve? SUMMARY ANSWER: A delay in IVF treatment up to 180 days does not affect the live birth rate for women with diminished ovarian reserve when compared to women who initiate IVF treatment within 90 days of presentation. WHAT IS KNOWN ALREADY: In clinical practice, treatment delays can occur due to medical, logistical or financial reasons. Over a period of years, a gradual decline in ovarian reserve occurs which can result in declining outcomes in response to IVF treatment over time. There is disagreement among reproductive endocrinologists about whether delaying IVF treatment for a few months can negatively affect patient outcomes. STUDY DESIGN, SIZE, DURATION: A retrospective cohort study of infertile patients in an academic hospital setting with diminished ovarian reserve who started an IVF cycle within 180 days of their initial consultation and underwent an oocyte retrieval with planned fresh embryo transfer between 1 January 2012 and 31 December 2018. PARTICIPANTS/MATERIALS, SETTING, METHODS: Diminished ovarian reserve was defined as an anti-Müllerian hormone (AMH) <1.1 ng/ml. In total, 1790 patients met inclusion criteria (1115 immediate and 675 delayed treatment). Each patient had one included cycle and no subsequent data from additional frozen embryo transfer cycles were included. Since all cycle outcomes evaluated were from fresh embryo transfers, no genetically tested embryos were included. Patients were grouped by whether their cycle started 1-90 days after presentation (immediate) or 91-180 days (delayed). The primary outcome was live birth (≥24 weeks of gestation). A subgroup analysis of more severe forms of diminished ovarian reserve was performed to evaluate outcomes for patients with an AMH <0.5 and for patients >40 years old with an AMH <1.1 ng/ml (Bologna criteria for diminished ovarian reserve). Logistic regression analysis, adjusted a priori for patient age, was used to estimate the odds ratio (OR) with a 95% CI. All pregnancy outcomes were additionally adjusted for the number of embryos transferred. MAIN RESULTS AND THE ROLE OF CHANCE: The mean ± SD number of days from presentation to IVF start was 50.5 ± 21.9 (immediate) and 128.8 ± 25.9 (delayed). After embryo transfer, the live birth rate was similar between groups (immediate: 23.9%; delayed: 25.6%; OR 1.08, 95% CI 0.85-1.38). Additionally, a similar live birth rate was observed in a subgroup analysis of patients with an AMH <0.5 ng/ml (immediate: 18.8%; delayed: 19.1%; OR 0.99, 95% CI 0.65-1.51) and in patients >40 years old with an AMH <1.1 ng/ml (immediate: 12.3%; delayed: 14.7%; OR 1.21, 95% CI 0.77-1.91). LIMITATIONS, REASONS FOR CAUTION: There is the potential for selection bias with regard to the patients who started their IVF cycle within 90 days compared to 91-180 days after initial consultation. In addition, we did not include patients who were seen for initial evaluation but did not progress to IVF treatment with oocyte retrieval; therefore, our results should only be applied to patients with diminished ovarian reserve who complete an IVF cycle. Finally, since we excluded patients who started their IVF cycle greater than 180 days from their first visit, it is not known how such a delay in treatment affects pregnancy outcomes in IVF cycles. WIDER IMPLICATIONS OF THE FINDINGS: A delay in initiating IVF treatment in patients with diminished ovarian reserve up to 180 days from the initial visit does not affect pregnancy outcomes. This observation remains true for patients who are in the high-risk categories for poor response to ovarian stimulation. Providers and patients should be reassured that when a short-term treatment delay is deemed necessary for medical, logistic or financial reasons, treatment outcomes will not be affected. STUDY FUNDING/COMPETING INTEREST(S): No financial support, funding or services were obtained for this study. The authors do not report any potential conflicts of interest. TRIAL REGISTRATION NUMBER: Not applicable.
引用
- Romanski PA, Bortoletto P, Rosenwaks Z, et al. Delay in IVF treatment up to 180 days does not affect pregnancy outcomes in women with diminished ovarian reserve. Hum Reprod. 2020. PMID: 32544225. doi:10.1093/humrep/deaa137
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。